Financhill
Sell
22

TSN Quote, Financials, Valuation and Earnings

Last price:
$57.72
Seasonality move :
9.51%
Day range:
$56.96 - $58.00
52-week range:
$51.16 - $66.88
Dividend yield:
3.41%
P/E ratio:
25.70x
P/S ratio:
0.39x
P/B ratio:
1.12x
Volume:
1.8M
Avg. volume:
2.6M
1-year change:
11.34%
Market cap:
$20.6B
Revenue:
$53.3B
EPS (TTM):
$2.25
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $43.2B $47B $53.3B $52.9B $53.3B
Revenue Growth (YoY) 1.84% 8.95% 13.25% -0.75% 0.81%
 
Cost of Revenues $37.8B $40.5B $46.6B $50.3B $49.7B
Gross Profit $5.4B $6.5B $6.7B $2.6B $3.6B
Gross Profit Margin 12.47% 13.87% 12.52% 4.98% 6.8%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.4B $2.1B $2.3B $2.2B $2.2B
Other Inc / (Exp) $131M $65M $87M -$739M $75M
Operating Expenses $2.4B $2.1B $2.3B $2.2B $2.2B
Operating Income $3B $4.4B $4.4B $386M $1.4B
 
Net Interest Expenses $475M $420M $348M $325M $392M
EBT. Incl. Unusual Items $2.7B $4B $4.1B -$678M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $593M $981M $900M -$29M $270M
Net Income to Company $2.1B $3.1B $3.2B -$649M $822M
 
Minority Interest in Earnings -$10M -$13M -$11M $1M -$22M
Net Income to Common Excl Extra Items $2.1B $3B $3.2B -$648M $800M
 
Basic EPS (Cont. Ops) $5.79 $8.57 $9.18 -$1.87 $2.31
Diluted EPS (Cont. Ops) $5.64 $8.34 $8.92 -$1.87 $2.25
Weighted Average Basic Share $363M $363M $360M $354M $354M
Weighted Average Diluted Share $365M $363M $363M $354M $356M
 
EBITDA $4.3B $5.7B $5.7B $1B $3B
EBIT $3.1B $4.5B $4.5B -$323M $1.6B
 
Revenue (Reported) $43.2B $47B $53.3B $52.9B $53.3B
Operating Income (Reported) $3B $4.4B $4.4B $386M $1.4B
Operating Income (Adjusted) $3.1B $4.5B $4.5B -$323M $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $11.5B $12.8B $13.7B $13.3B $13.6B
Revenue Growth (YoY) 5.29% 11.79% 7.23% -2.83% 1.63%
 
Cost of Revenues $9.9B $10.3B $12.4B $12.9B $12.5B
Gross Profit $1.6B $2.5B $1.3B $459M $1.1B
Gross Profit Margin 14.05% 19.33% 9.52% 3.44% 7.81%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $648M $567M $541M $589M $535M
Other Inc / (Exp) -$2M $27M -$24M -$341M $51M
Operating Expenses $648M $567M $541M $589M $535M
Operating Income $962M $1.9B $766M -$130M $525M
 
Net Interest Expenses $123M $101M $76M $85M $101M
EBT. Incl. Unusual Items $837M $1.8B $666M -$556M $475M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $180M $477M $129M -$113M $111M
Net Income to Company $657M $1.4B $537M -$443M $364M
 
Minority Interest in Earnings -$3M -$3M $1M -$7M -$7M
Net Income to Common Excl Extra Items $654M $1.4B $538M -$450M $357M
 
Basic EPS (Cont. Ops) $1.95 $3.81 $1.54 -$1.31 $1.03
Diluted EPS (Cont. Ops) $1.90 $3.71 $1.50 -$1.31 $1.00
Weighted Average Basic Share $363M $363M $357M $351M $354M
Weighted Average Diluted Share $363M $363M $360M $351M $359M
 
EBITDA $1.3B $2.2B $1.1B -$67M $923M
EBIT $961M $1.9B $749M -$463M $605M
 
Revenue (Reported) $11.5B $12.8B $13.7B $13.3B $13.6B
Operating Income (Reported) $962M $1.9B $766M -$130M $525M
Operating Income (Adjusted) $961M $1.9B $749M -$463M $605M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $43.2B $47B $53.3B $52.9B $53.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $37.8B $40.5B $46.6B $50.3B $49.7B
Gross Profit $5.4B $6.5B $6.7B $2.6B $3.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.4B $2.1B $2.3B $2.2B $2.2B
Other Inc / (Exp) $131M $65M $87M -$739M $75M
Operating Expenses $2.4B $2.1B $2.3B $2.2B $2.2B
Operating Income $3B $4.4B $4.4B $386M $1.4B
 
Net Interest Expenses $475M $420M $348M $325M $392M
EBT. Incl. Unusual Items $2.7B $4B $4.1B -$678M $1.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $593M $981M $900M -$29M $270M
Net Income to Company $2.1B $3.1B $3.2B -$649M $822M
 
Minority Interest in Earnings -$10M -$13M -$11M $1M -$22M
Net Income to Common Excl Extra Items $2.1B $3B $3.2B -$648M $800M
 
Basic EPS (Cont. Ops) $5.91 $8.57 $9.18 -$1.86 $2.31
Diluted EPS (Cont. Ops) $5.75 $8.34 $8.92 -$1.89 $2.25
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $4.3B $5.7B $5.7B $1B $3B
EBIT $3.1B $4.5B $4.5B -$323M $1.6B
 
Revenue (Reported) $43.2B $47B $53.3B $52.9B $53.3B
Operating Income (Reported) $3B $4.4B $4.4B $386M $1.4B
Operating Income (Adjusted) $3.1B $4.5B $4.5B -$323M $1.6B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $47B $53.3B $52.9B $53.3B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $40.5B $46.6B $50.3B $49.7B --
Gross Profit $6.5B $6.7B $2.6B $3.6B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.1B $2.3B $2.2B $2.2B --
Other Inc / (Exp) $65M $87M -$739M $75M --
Operating Expenses $2.1B $2.3B $2.2B $2.2B --
Operating Income $4.4B $4.4B $386M $1.4B --
 
Net Interest Expenses $420M $348M $325M $392M --
EBT. Incl. Unusual Items $4B $4.1B -$678M $1.1B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $981M $900M -$29M $270M --
Net Income to Company $3.1B $3.2B -$649M $822M --
 
Minority Interest in Earnings -$13M -$11M $1M -$22M --
Net Income to Common Excl Extra Items $3B $3.2B -$648M $800M --
 
Basic EPS (Cont. Ops) $8.57 $9.18 -$1.86 $2.31 --
Diluted EPS (Cont. Ops) $8.34 $8.92 -$1.89 $2.25 --
Weighted Average Basic Share $1.5B $1.4B $1.4B $1.4B --
Weighted Average Diluted Share $1.5B $1.5B $1.4B $1.4B --
 
EBITDA $5.7B $5.7B $1B $3B --
EBIT $4.5B $4.5B -$323M $1.6B --
 
Revenue (Reported) $47B $53.3B $52.9B $53.3B --
Operating Income (Reported) $4.4B $4.4B $386M $1.4B --
Operating Income (Adjusted) $4.5B $4.5B -$323M $1.6B --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.4B $2.5B $1B $573M $1.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2B $2.4B $2.6B $2.5B $2.4B
Inventory $3.9B $4.4B $5.5B $5.3B $5.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $367M $533M $508M $345M $433M
Total Current Assets $7.6B $9.8B $9.6B $8.7B $9.8B
 
Property Plant And Equipment $7.6B $7.8B $8.7B $9.6B $9.4B
Long-Term Investments -- -- -- -- --
Goodwill $10.9B $10.5B $10.5B $9.9B $9.8B
Other Intangibles $6.8B $6.5B $6.3B $6.1B $5.9B
Other Long-Term Assets $1.6B $1.6B $1.7B $1.9B $2.2B
Total Assets $34.5B $36.3B $36.8B $36.3B $37.1B
 
Accounts Payable $1.9B $2.2B $2.5B $2.6B $2.4B
Accrued Expenses $841M $1.5B $1.2B $961M $1.3B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $817M $840M $884M $893M $840M
Total Current Liabilities $4.2B $6.3B $5.3B $6.5B $4.8B
 
Long-Term Debt $10.8B $8.3B $7.9B $7.6B $9.7B
Capital Leases -- -- -- -- --
Total Liabilities $19.1B $18.5B $17B $18B $18.6B
 
Common Stock $45M $45M $45M $45M $45M
Other Common Equity Adj -$179M -$172M -$297M -$260M -$184M
Common Equity $15.3B $17.7B $19.7B $18.1B $18.4B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $132M $131M $109M $122M $124M
Total Equity $15.4B $17.9B $19.8B $18.3B $18.5B
 
Total Liabilities and Equity $34.5B $36.3B $36.8B $36.3B $37.1B
Cash and Short Terms $1.4B $2.5B $1B $573M $1.7B
Total Debt $11.3B $9.3B $8.3B $9.5B $9.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.4B $2.5B $1B $573M $1.7B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2B $2.4B $2.6B $2.5B $2.4B
Inventory $3.9B $4.4B $5.5B $5.3B $5.2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $367M $533M $508M $345M $433M
Total Current Assets $7.6B $9.8B $9.6B $8.7B $9.8B
 
Property Plant And Equipment $7.6B $7.8B $8.7B $9.6B $9.4B
Long-Term Investments -- -- -- -- --
Goodwill $10.9B $10.5B $10.5B $9.9B $9.8B
Other Intangibles $6.8B $6.5B $6.3B $6.1B $5.9B
Other Long-Term Assets $1.6B $1.6B $1.7B $1.9B $2.2B
Total Assets $34.5B $36.3B $36.8B $36.3B $37.1B
 
Accounts Payable $1.9B $2.2B $2.5B $2.6B $2.4B
Accrued Expenses $841M $1.5B $1.2B $961M $1.3B
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $817M $840M $884M $893M $840M
Total Current Liabilities $4.2B $6.3B $5.3B $6.5B $4.8B
 
Long-Term Debt $10.8B $8.3B $7.9B $7.6B $9.7B
Capital Leases -- -- -- -- --
Total Liabilities $19.1B $18.5B $17B $18B $18.6B
 
Common Stock $45M $45M $45M $45M $45M
Other Common Equity Adj -$179M -$172M -$297M -$260M -$184M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $132M $131M $109M $122M $124M
Total Equity $15.4B $17.9B $19.8B $18.3B $18.5B
 
Total Liabilities and Equity $34.5B $36.3B $36.8B $36.3B $37.1B
Cash and Short Terms $1.4B $2.5B $1B $573M $1.7B
Total Debt $11.3B $9.3B $8.3B $9.5B $9.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.1B $3.1B $3.2B -$649M $822M
Depreciation & Amoritzation $1.2B $1.2B $1.2B $1.3B $1.4B
Stock-Based Compensation $89M $91M $93M $61M $101M
Change in Accounts Receivable $191M -$508M -$176M $136M $59M
Change in Inventories $86M -$567M -$1.2B $175M $153M
Cash From Operations $3.9B $3.8B $2.7B $1.8B $2.6B
 
Capital Expenditures $1.2B $1.2B $1.9B $1.9B $1.1B
Cash Acquisitions -$154M $1.1B -$177M -$377M $145M
Cash From Investing -$1.4B $58M -$1.9B -$2.3B -$888M
 
Dividends Paid (Ex Special Dividend) -$601M -$636M -$653M -$670M -$684M
Special Dividend Paid
Long-Term Debt Issued $17.1B $585M $103M $8.8B $4.1B
Long-Term Debt Repaid -$17.8B -$2.6B -$1.2B -$7.7B -$3.9B
Repurchase of Common Stock -$207M -$67M -$702M -$354M -$49M
Other Financing Activities -$18M -$22M -$6M -$16M -$45M
Cash From Financing -$1.5B -$2.7B -$2.3B $88M -$581M
 
Beginning Cash (CF) $484M $1.5B $2.6B $1B $573M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $983M $907M -$1.6B -$459M $1.1B
Ending Cash (CF) $1.5B $2.5B $1B $573M $1.7B
 
Levered Free Cash Flow $2.7B $2.6B $800M -$187M $1.5B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $657M $1.4B $537M -$443M $364M
Depreciation & Amoritzation $316M $308M $310M $396M $318M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- $136M $59M
Change in Inventories -- -- -- $175M $153M
Cash From Operations $1.2B $1.2B $797M $323M $617M
 
Capital Expenditures $292M $350M $564M $375M $248M
Cash Acquisitions -- $1.2B -$80M -$65M $173M
Cash From Investing -$280M $841M -$610M -$427M -$34M
 
Dividends Paid (Ex Special Dividend) -$150M -$159M -$162M -$167M -$171M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$26M $12M $24M $691M $69M
Long-Term Debt Repaid -$681M -$1B -$43M -$516M -$1.3B
Repurchase of Common Stock -$7M -$17M -$9M -$11M -$5M
Other Financing Activities -$11M -$9M -$6M -$11M -$23M
Cash From Financing -$874M -$1.2B -$195M -$13M -$1.5B
 
Beginning Cash (CF) $1.4B $1.6B $1.1B $699M $2.6B
Foreign Exchange Rate Adjustment $7M -$7M -$17M -$9M $29M
Additions / Reductions $12M $576M -$8M -$117M -$881M
Ending Cash (CF) $1.5B $2.5B $1B $573M $1.7B
 
Levered Free Cash Flow $874M $834M $233M -$52M $369M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.1B $3.1B $3.2B -$649M $822M
Depreciation & Amoritzation $1.2B $1.2B $1.2B $1.3B $1.4B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $3.9B $3.8B $2.7B $1.8B $2.6B
 
Capital Expenditures $1.2B $1.2B $1.9B $1.9B $1.1B
Cash Acquisitions -$154M $1.1B -$177M -$377M $145M
Cash From Investing -$1.4B $58M -$1.9B -$2.3B -$888M
 
Dividends Paid (Ex Special Dividend) -$601M -$636M -$653M -$670M -$684M
Special Dividend Paid
Long-Term Debt Issued $17.1B $585M $103M $8.8B $4.1B
Long-Term Debt Repaid -$17.8B -$2.6B -$1.2B -$7.7B -$3.9B
Repurchase of Common Stock -$207M -$67M -$702M -$354M -$49M
Other Financing Activities -$18M -$22M -- -- -$45M
Cash From Financing -$1.5B -$2.7B -$2.3B $88M -$581M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $983M $907M -$1.6B -$459M $1.1B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.7B $2.6B $800M -$187M $1.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $3.1B $3.2B -$649M $822M --
Depreciation & Amoritzation $1.2B $1.2B $1.3B $1.4B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- $136M $59M --
Change in Inventories -- -- $175M $153M --
Cash From Operations $3.8B $2.7B $1.8B $2.6B --
 
Capital Expenditures $1.2B $1.9B $1.9B $1.1B --
Cash Acquisitions $1.1B -$177M -$377M $145M --
Cash From Investing $58M -$1.9B -$2.3B -$888M --
 
Dividends Paid (Ex Special Dividend) -$636M -$653M -$670M -$684M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $585M $103M $8.8B $4.1B --
Long-Term Debt Repaid -$2.6B -$1.2B -$7.7B -$3.9B --
Repurchase of Common Stock -$67M -$702M -$354M -$49M --
Other Financing Activities -$22M -$6M -$16M -$45M --
Cash From Financing -$2.7B -$2.3B $88M -$581M --
 
Beginning Cash (CF) $6.4B $7.8B $2.9B $6.8B --
Foreign Exchange Rate Adjustment $4M -$35M $1M $23M --
Additions / Reductions $907M -$1.6B -$459M $1.1B --
Ending Cash (CF) $7.4B $6.2B $2.5B $8B --
 
Levered Free Cash Flow $2.6B $800M -$187M $1.5B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is up 6.85% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is up 0.85% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is down 0.55% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock